tgen Archives

TGen, Dell help children with cancer

childrens hospital

Dell, Terascala and the Translational Genomics Research Institute (TGen) are installing state-of-the-art computing and programing specialized for human genome investigations at the National Cancer Institute (NCI). As part of a formal collaboration, Dell is providing the Dell Genomic Data Analysis Platform, designed to deliver fast analysis of the billions of data points required when sequencing,… Read More →

TGen fundraising event moves to Scottsdale

slide_all2

The 9th annual stepNout Run, Walk Dash, a major fundraising event for pancreatic cancer research at the Translational Genomics Research Institute (TGen), is moving to the Scottsdale Sports Complex. More than 1,000 participants have attended stepNout in each of the past few years, and even more are expected to attend this year’s morning-long event on… Read More →

TGen-Ivy Foundation brain cancer trial approved

brain

In 2012, The Ben & Catherine Ivy Foundation awarded $10 million in grants for two groundbreaking brain cancer research projects at the Translational Genomics Research Institute (TGen). One of those projects has officially received the final regulatory approval from University of California, San Francisco, which means patient enrollment for the trial can begin. In the… Read More →

‘Get Your Jersey On’ funds TGen concussion study

brain

Kyrene de las Brisas Elementary School students and teachers will wear their favorite sports team jersey or t-shirt to class today, the first organization to participate in “Get Your Jersey On,” a fun way to help promote and fund concussion research at the Translational Genomics Research Institute (TGen). The Chandler school is the first of… Read More →

ASU, TGen Team Up for Concussion Research

Conquering Concussions

Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute (TGen), a leader in cutting-edge genomic research, today announced that the Pac-12’s Arizona State University and its Sun Devil football program will again participate in a genetic research study designed to advance athlete concussion detection and treatment. Now in its… Read More →

NIH awards BAI, Mayo $8.3 million

Medical Technology - AZ Business Magazine January/February 2012

The National Institutes of Health (NIH) renewed funding for the Banner Alzheimer’s Institute (BAI) and Mayo Clinic, Phoenix, longitudinal study of the earliest changes associated with the risk of developing Alzheimer’s disease at older ages. The award, an estimated $8.3 million over the next five years, continues NIH’s long-term support of the investigation. The study,… Read More →

Helios Scholars at TGen featured at symposium

bioscience

The 45 interns in the 2014 Helios Scholars at TGen summer internship program graduated today, following a daylong scientific symposium at the Sheraton Phoenix Downtown Hotel. Arizona’s future leaders in biology and medicine worked for eight weeks in one of the nation’s premier scientific internship programs, sponsored by the Helios Education Foundation in partnership with… Read More →

TGen study provides new insights on HIV

Hiv+Aids+xgold+2012

A new study led by the Translational Genomics Research Institute (TGen) provides insights into the interplay among bacteria, viruses and the immune system during HIV infection. Currently, doctors measure HIV-positive men’s infectivity — their potential to infect others — based on their blood viral load. However, some men produce large amounts of virus in their… Read More →

TGen study finds origin of lung fungus

Cryptococcus gattii, a virulent fungus that has invaded the Pacific Northwest is highly adaptive and warrants global “public health vigilance,” according to a study by an international team led by the Translational Genomics Research Institute (TGen). C. gattii, which likely originated in Brazil, is responsible for dozens of deaths in recent years since it was… Read More →

TGen teams up with Ceres Nanosciences

bioscience

The Translational Genomics Research Institute (TGen) and Ceres Nanosciences, Inc. (Ceres) today announced a development collaboration to benefit patients with cancer, infectious diseases, and other life-threatening illnesses. TGen, at the heart of Phoenix’s Biomedical Campus, is recognized as a pioneer in studying genomics, or DNA, to uncover the underlying molecular causes of disease, as well… Read More →

TGen, SHC begin clinical trial for anti-tumor drug

The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, especially those with brain tumors and gallbladder bile duct cancer. “AG-120 is designed specifically for those patients who carry the IDH1… Read More →

TGen and NAU celebrate 5-year research pact

stem.cell

Northern Arizona University (NAU) and the Translational Genomics Research Institute (TGen) announced a five-year agreement to promote innovation and quality research benefiting Arizona. The NAU-TGen Memorandum of Understanding (MOU) implements the allocation of state funding as directed by Governor Jan Brewer and the Arizona Legislature, and reaffirms the commitment of both institutions toward quality research,… Read More →

Pancreatic cancer drug successfully tested by TGen

bioscience

A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM-398, given in combination with 5-flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously-treated pancreatic cancer.… Read More →

Gordon named clinical trials medical director

Michael Gordon MD

Michael S. Gordon, MD, one of the greater Phoenix area’s leading medical oncologists and cancer researchers, has been named the new Medical Director for the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare. Dr. Gordon will oversee the center’s internationally recognized Phase I clinical trials program, which is known for its leadership… Read More →